Posted by Michael Wonder on 05 Jul 2016
TGA publishes AusPAR for asfotase alfa (Strensiq)
5 July 2016 - The TGA has published an AusPAR for Alexion Pharmaceuticals' Strensiq.
The TGA approved asfotase alfa (Strensiq) on 12 January 2016 for use as enzyme replacement therapy in patients with paediatric onset hypophosphatasia.
